BETHLEHEM, PA – September 21, 2017 — B. Braun Medical Inc. will reinforce its commitment to reducing healthcare-acquired infections when it launches new products next month that help reduce bacterial contamination of stopcocks and other IV connectors in the surgical suite.
At ANESTHESIOLOGY 2017, the American Society of Anesthesiologists (ASA) meeting, Oct. 21-23 in Boston, B. Braun will present the SAXA Anesthesia Disinfection Workstation. The workstation includes the new DOCit™ and HubScrub™ disposable disinfection devices, which are designed to help organize the anesthesia work space in an operating room. The DOCit device is intended to disinfect and clean syringe tips and male luer connectors, and the HubScrub device is intended to disinfect and clean needleless connectors and stopcocks.
“In collaboration with SAXA Medical Solutions, LLC, B. Braun is bringing to surgical suites the Anesthesia Disinfection Workstation system, which can help reduce stopcock contamination,”1 said Steve Weber, Director of Marketing, IV Systems at B. Braun. “It’s designed to improve intravascular device disinfection in the operating room, which in turn can help reduce healthcare-acquired infections.”
The DOCit device is designed to organize and protect syringe tips and other male luer connectors from contamination. The DOCit device scrubs and disinfects male luer tip connectors and needleless syringes with 70 percent isopropyl alcohol (IPA). Disinfection of the male luer tip occurs after two 360-degree rotations within 10 seconds.2
The HubScrub device is a female luer disinfector and cleaner with 70 percent IPA. Disinfection of the needleless connector is achieved after two 360-degree rotations within 10 seconds.2 The HubScrub device can provide a microbial barrier to contamination for up to 7 days if not removed.3
ASA attendees can learn more about the SAXA Anesthesia Disinfection Workstation and DOCit and HubScrub devices at the B. Braun booth #3126 at the Boston Convention and Exhibition Center.
In addition, B. Braun will sponsor “Improving Intravascular Device Disinfection in Today’s Operating Rooms: Clinical Implications, Methodology and Fidelity Measurement” presented by Randy Loftus, M.D., Associate Professor, Anesthesiology. The presentation, to be held adjunct from ASA, will be at the Renaissance Boston Waterfront Hotel from 6:30 to 7:45 a.m. on Sunday, Oct. 22. Complimentary breakfast will be served from 6 to 6:30 a.m. To register, visit www.BBraunKnowledge.com. The event does not qualify for continuing medical education (CME).
For more information, visit www.BBraunUSA.com .
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety.
B. Braun Medical is headquartered in Bethlehem, PA, and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
SAXA Medical Solutions, LLC is the manufacturer of the DOCit™ and HubScrub™ devices. DOCit and HubScrub are registered trademarks of SAXA Medical Solutions, LLC. B. Braun is a distributor of the Anesthesia Disinfection Workstation, DOCit and HubScrub.
1. Loftus, R., et al. Reduction in Intraoperative Bacterial Contamination of Peripheral Intravenous Tubing Through the Use of a Passive Catheter System, Anesthesia-Analgesia, December 2012; Volume 115; Number 6.
2. T16-037 Rev. 01 data on file with SAXA Medical Solutions.
3. Laboratory Number 801789 data on file with SAXA Medical Solutions.